完全冠状动脉闭塞患者经皮或外科血运重建后10年死亡率
SYNTAXES研究是对SYNTAX试验的10年随访分析,纳入1800例随机接受PCI或CABG的患者,其中460例至少存在1处完全闭塞(TO)。分析显示,在TO患者中,无论 assigned 治疗如何,TO再通或血运重建状态与10年全因死亡率无关;当TO位于左主干和/或左前降支时,再通状态对死亡率亦无影响。
要点
- TO再通或血运重建状态未显著影响10年全因死亡率。
- PCI arm中TO再通与否死亡率分别为29.9%与29.4%(校正HR 0.992)。
- CABG arm中TO再通与否死亡率分别为28.0%与21.4%(校正HR 0.656)。
核心结论
- 在10年随访时,TO再通或血运重建状态不影响死亡率,与 assigned 治疗和TO位置无关。
- 研究结果可能支持在高容量慢性TO-PCI中心,仅对药物治疗无效且心肌存活确认的心绞痛患者行再通。
研究设计与样本
- SYNTAXES研究是对SYNTAX试验的10年全因死亡率分析,为随机对照试验的亚组分析。
- 共1800例随机分配至PCI或CABG臂的患者,其中460例至少存在1处TO病变。
主要发现
- PCI臂:TO再通或血运重建与否的10年全因死亡率分别为29.9%与29.4%(校正HR 0.992;95%CI 0.474-2.075;p=0.982)。
- CABG臂:TO再通或血运重建与否的10年全因死亡率分别为28.0%与21.4%(校正HR 0.656;95%CI 0.281-1.533;p=0.330)。
- 当TO位于左主干和/或左前降支时,再通状态对死亡率无影响(34.5% vs 26.9%;校正HR 0.896;95%CI 0.314-2.555;p=0.837)。
临床怎么用
- 对于合并TO的复杂冠心病患者,再通决策应个体化,尤其需考虑症状与心肌存活证据。
- 在 high-volume 慢性TO-PCI中心,再通可能主要针对药物治疗无效且心肌存活确认的心绞痛患者。
局限性
- 本研究为SYNTAX试验的亚组分析,TO患者样本量有限(460例)。
- TO再通或血运重建状态非随机分配,可能存在混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term clinical benefit after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with total occlusions (TOs) and complex coronary artery disease has not yet been clarified. OBJECTIVES: The objective of this analysis was to assess 10-year all-cause mortality in patients with TOs undergoing PCI or CABG. METHODS: This is a subanalysis of patients with at least 1 TO in the SYNTAXES (Synergy Between PCI With Taxus and Cardiac Surgery Extended Survival) study, which investigated 10-year all-cause mortality in the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) trial, beyond its original 5-year follow-up. Patients with TOs were further stratified according to the status of TO recanalization or revascularization. RESULTS: Of 1,800 randomized patients to the PCI or CABG arm, 460 patients had at least 1 lesion of TO. In patients with TOs, the status of TO recanalization or revascularization was not associated with 10-year all-cause mortality, irrespective of the assigned treatment (PCI arm: 29.9% vs. 29.4%; adjusted hazard ratio [HR]: 0.992; 95% confidence interval [CI]: 0.474 to 2.075; p = 0.982; and CABG arm: 28.0% vs. 21.4%; adjusted HR: 0.656; 95% CI: 0.281 to 1.533; p = 0.330). When TOs existed in left main and/or left anterior descending artery, the status of TO recanalization or revascularization did not have an impact on the mortality (34.5% vs. 26.9%; adjusted HR: 0.896; 95% CI: 0.314 to 2.555; p = 0.837). CONCLUSIONS: At 10-year follow-up, the status of TO recanalization or revascularization did not affect mortality, irrespective of the assigned treatment and location of TOs. The present study might support contemporary practice among high-volume chronic TO-PCI centers where recanalization is primarily offered to patients for the management of angina refractory to medical therapy when myocardial viability is confirmed. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NCT03417050; SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries [SYNTAX]; NCT00114972).
引用
- Kawashima H, Takahashi K, Ono M, et al. Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions. J Am Coll Cardiol. 2021. PMID: 33538250. doi:10.1016/j.jacc.2020.11.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。